Dr Max Fehlmann

Mark Henderson
February 14, 2017

Dr Max Fehlmann has been appointed president and CEO of the Canadian Cancer Society, effective January 16, replacing Andy Chabot after an eight-year term. Fehlmann stepped down as the founding president and CEO of the NEOMED Institute and NEOMED-LABS, its affiliate contract research organization at the end of 2016. Prior to founding NEOMED in 2012, he founded the Consortium Québécois pour la Découverte du Médicament (CQDM) in 2008, a public-private non-profit organization financing precompetitive research in drug discovery. Fehlmann received his PhD in molecular biology from Laval Univ and holds a DSc from the Univ of Nice and an MBA from HEC-CPA in Sophia-Antipolis in Nice. He has more than 35 years of experience in management, financing and business development.


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.